Risk
- •
Prevalence: Estimates ranging from 1.7-3.6%.
- •
Most common cause is vitamin deficiency: 65% vitamin B12; 12% combined folate/vitamin B12; 6% folate.
- •
Pernicious anemia is less common: 1 in 7500 people in USA develops pernicious anemia each year.
- •
Prevalence increases with advanced age and in countries with higher rates of malnutrition.
Worry About
- •
Exaggerated effect of myocardial depression from anesthesia.
- •
Preoperative treatment should include supplementation of B12 and folate or transfusion in setting of severe anemia and emergent surgery.
- •
Decreased platelet count and coagulopathy.
- •
Anemia causing MI, stroke, or resp failure.
Overview
- •
An anemia caused by a failure of DNA synthesis which results in large, structurally abnormal and immature red blood cells called megaloblasts (MCV >100 fL/cell).
- •
Often WBC and platelet counts are also decreased.
- •
Anemia develops insidiously and due to physiologic compensatory mechanisms it may not cause symptoms until it is severe.
- •
Symptoms: Fatigue, pallor, dyspnea on exertion, headache, dizziness, tachycardia, nausea, diarrhea, glossitis, and jaundice.
- •
Vitamin B12 deficiency can interfere with myelination and produce peripheral neuropathy which varies from subtle loss of vibratory sensation and proprioception to frank dementia.
Treatment
- •
The treatment of megaloblastic anemia depends upon the underlying cause of the disorder.
- •
Diagnose with complete blood counts, red cell indices, and assays of the vitamin B12 and folate.
- •
Dietary insufficiency of cobalamin and folate can be treated with appropriate changes to the diet and the administration of supplements.
- •
Vitamin B12 1000-2000 μg orally can be given once per d but if pts have neurologic signs, vitamin B12 1 mg IM is usually given 1 to 4 times/wk for several wk.
- •
Folate 400-1000 μg orally once per d.
- •
Vitamin B12 deficiency must be ruled out before treating with folate alone as this would treat anemia but not the neurologic manifestations.